Abstract:Epilepsy is a common chronic neurological disorder that is controlled with medication in approximately 70% of cases. When partial seizures are recurrent despite the use of antiepileptic drugs, resection of the epileptogenic cortex may be considered. Nuclear medicine plays an important role in the presurgical assessment of patients with refractory epilepsy. Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) techniques are used to determine the seizure onset zone, which needs to be resected to render a patient seizure free. Correct localization of the ictal onset zone with the use of SPECT or PET is associated with a better surgical outcome. Ictal perfusion SPECT imaging with (99m)Tc-ethyl cysteinate dimer (ECD) or (99m)Tc-hexamethylpropyleneamine oxime (HMPAO) enables one to detect the seizure onset zone in a majority of cases, especially in patients with temporal lobe epilepsy. Interictal SPECT imaging, which is more widely available, is unreliable to determine the ictal onset zone and is usually only used for comparison with ictal SPECT images. Assessment of the ictal onset zone using subtracted ictal and interictal studies, overlayed on structural imaging has proven to be more sensitive and more specific compared with visual assessment. Video-electroencephalography monitoring in combination with ictal SPECT imaging, however, is only available in specialized centers. It is important to inject the perfusion tracer as early as possible after the beginning of a seizure and to be aware of patterns of seizure propagation. Interictal (18)F-fluorodeoxyglucose (FDG)-PET is routinely used to detect brain areas of hypometabolism, which usually encompass, but tend to be larger than, the seizure onset zone. Also, for assessment of FDG-PET, it is advisable to use an automated technique comparing the patient's images to a normal database in addition to visual interpretation of the images, since automated techniques have proven to be more accurate. In view of the thickness of the cortical ribbon, which may be below the resolution of the PET camera, posthoc partial volume correction or PET reconstruction incorporating the anatomical information of magnetic resonance imaging (MRI), may be useful for optimal assessment of glucose metabolism. Perfusion SPECT and interictal FDG-PET are able to demonstrate areas of abnormal perfusion and metabolism at a distance from the ictal onset zone, which may be associated with cognitive and psychiatric comorbidities, and may represent the functional deficit zone in epilepsy. Part of the functional deficit zone is a dynamic seizure-related process, which may resolve with cessation of seizures. In recent years, novel PET tracers have been developed to visualize not only glucose metabolism but also a wide variety of specific receptor systems. In patients with epilepsy, changes in the gamma-amino-butyric acid(A) receptor, opioid receptor, 5-HT(1A) serotonin receptor, nicotinic acetylcholine receptor systems, and others have been described. Because these tracers are not widely available and the superiority of studying these receptor systems over glucose metabolism in the presurgical evaluation of patients with refractory epilepsy remains to be proven, their use in clinical practice is limited at the moment. Finally, advances in small animal PET scanning allow the in vivo study of the process of epileptogenesis, starting from an initial brain insult to the development of seizures, in animal models of epilepsy. Potential new therapeutic targets may be discovered using this translational approach.

PET/MRI in refractory epilepsy

Image post-processing in magnetic resonance imaging-negative focal epilepsy

Linking Mri Postprocessing with Magnetic Source Imaging in Mri-Negative Epilepsy

The neural function analysis based on PET/CT localization of the MRI negative epilepsy The neural function analysis based on PET/CT localization of the MRI negative epilepsy

The Diagnostic Value of 18F-FDG PET/MRI in MR-positive Refractory Epilepsy

Comparative Study of PET Imaging with EEG and MRI in Patients with Intractable Epilepsy

Comparative Study on Diagnosis of Refractory Epilepsy by PET/CT, EEG and MRI

Application of medical images in localization of epileptic foci

Simultaneous 18F-FDG PET/MRI predicting favourable surgical outcome in refractory epilepsy patients

Utility of Hybrid PET/MRI in Stereoelectroencephalography Guided Radiofrequency Thermocoagulation in MRI Negative Epilepsy Patients

Application of MRI Post-processing in Presurgical Evaluation of Non-lesional Cingulate Epilepsy.

18F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy

Application Study of SPM5 in Analysis of PET Imaging for Epilepsy Patient

Application of Positron Emission Computed Tomography/magnetic Resonance Imaging Coregistration in Improving Epileptic Foci Detection Rate of Structural Intractable Epilepsy in Children

Localizing Epileptic Foci Before Surgery in Patients With MRI-Negative Refractory Epilepsy Using Statistical Parameter Mapping and Three-Dimensional Stereotactic Surface Projection Based on 18F-FDG PET

Yield of MRI, high-density electric source imaging (HD-ESI), SPECT and PET in epilepsy surgery candidates

Advances in Neuroimaging and Multiple Post-Processing Techniques for Epileptogenic Zone Detection of Drug-Resistant Epilepsy

Neuronuclear assessment of patients with epilepsy

Utility of hybrid PET/MRI multiparametric imaging in navigating SEEG placement in refractory epilepsy

A deep learning framework for 18 F-FDG PET imaging diagnosis in pediatric patients with temporal lobe epilepsy

7T MRI with Post-Processing for the Presurgical Evaluation of Pharmacoresistant Focal Epilepsy.